Description
Tadalafil (50 x 20mg), marketed as Cialis®, is a selective phosphodiesterase type 5 (PDE5) inhibitor with multiple therapeutic applications:
Clinical Indications:
• Erectile dysfunction treatment (5-20 mg dosing)
• Benign prostatic hyperplasia symptom management (5 mg daily)
• Pulmonary arterial hypertension (40 mg daily)
Pharmacological Profile:
Extended duration of action (up to 36 hours clinical effect)
Rapid absorption (Tmax = 2 hours)
High protein binding (94%)
Hepatic metabolism via CYP3A4
Research Applications:
Vascular endothelial function studies
Lower urinary tract pathophysiology
Chronic pulmonary circulation research
Gender-specific vascular response analysis
Mechanistic Action:
Potentiates nitric oxide-mediated vasodilation
Increases smooth muscle cGMP concentrations
Demonstrates tissue selectivity in urogenital vasculature
Current Research Focus:
✔ Dose optimization protocols
✔ Long-term vascular health impacts
✔ Combination therapy potential
Note: The compound requires sexual stimulation for therapeutic effect and is contraindicated with nitrate medications. Ongoing research investigates its pharmacokinetic profile and potential applications in vascular medicine. Available product may not match displayed product image.





Reviews
There are no reviews yet.